Search Results - Matthew Angel
- Showing 1 - 5 results of 5
-
1
Step-dose IL-7 treatment promotes systemic expansion of T cells and alters immune cell landscape in blood and lymph nodes by Hrishikesh Pandit, Antonio Valentin, Matthew Angel, Claire Deleage, Cristina Bergamaschi, Jenifer Bear, Raymond Sowder, Barbara K. Felber, George N. Pavlakis
Published in iScience (2023-02-01)Get full text
Article -
2
Tumor eradication by hetIL-15 locoregional therapy correlates with an induced intratumoral CD103intCD11b+ dendritic cell population by Dimitris Stellas, Sevasti Karaliota, Vasiliki Stravokefalou, Matthew Angel, Bethany A. Nagy, Katherine C. Goldfarbmuren, Cristina Bergamaschi, Barbara K. Felber, George N. Pavlakis
Published in Cell Reports (2023-05-01)Get full text
Article -
3
Paradoxical imbalance between activated lymphocyte protein synthesis capacity and rapid division rate by Mina O Seedhom, Devin Dersh, Jaroslav Holly, Mariana Pavon-Eternod, Jiajie Wei, Matthew Angel, Lucas Shores, Alexandre David, Jefferson Santos, Heather Hickman, Jonathan W Yewdell
Published in eLife (2024-03-01)Get full text
Article -
4
Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs. by Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova, Matthew Angel, Javier G Magadán, Hang Xie, Christopher B Brooke, Jonathan W Yewdell
Published in PLoS Pathogens (2018-06-01)Get full text
Article -
5
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs. by Ivan Kosik, William L Ince, Lauren E Gentles, Andrew J Oler, Martina Kosikova, Matthew Angel, Javier G Magadán, Hang Xie, Christopher B Brooke, Jonathan W Yewdell
Published in PLoS Pathogens (2018-01-01)Get full text
Article
